Data from the 28-week extension of the LIBERTY EoE TREET phase 3 clinical trial showed that the anti–interleukin-4/IL-13 antibody dupilumab […]
- Home
- nos
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok